Image

Efficacy of Osimertinib in Patients With Lung Cancer

Efficacy of Osimertinib in Patients With Lung Cancer

Not Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

This is a descriptive observational study, in which data are collected in an epidemiological fashion and prospective. This study does not intend to intervene the current medical practice of the recruited patients.

Eligibility

Inclusion Criteria:

  • Patients must be ≥18 years.
  • Provision of fully informed consent prior to any study specific procedures.
  • Advanced or metastatic lung squamous cell carcinoma confirmed by histology or cytology.
  • According to the RECIST 1.1 standard, the patient must have at least one measurable lesion.

Exclusion Criteria:

  • None

Study details
    Advanced Non-Small Cell Lung Cancer

NCT06174857

Hunan Province Tumor Hospital

30 January 2026

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.